Skip to content
Author(s): WHO
Filed under:
DR-TB,
drug safety,
drug safety monitoring,
Drug-resistant TB,
Guidelines,
Management,
management framework,
performance indicators,
TB,
Treatment,
treatment regimens,
Tuberculosis,
WHO,
World Health Organization